Literature DB >> 16955221

Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery.

Frits Thorsen1, Per Øyvind Enger, Jian Wang, Rolf Bjerkvig, Paal-Henning Pedersen.   

Abstract

BACKGROUND: The Gamma Knife is currently used to boost treatment of malignant gliomas. However, few experimental studies have focused on its radiobiological effects. In this work, the growth and invasiveness of human glioblastoma spheroids xenografted into nude rat brains were assessed after radiosurgery. Temporary in vitro as well as long-term in vivo radiation effects were studied.
METHODS: Glioblastoma biopsy spheroids were irradiated with 12 or 24 Gy. Short-term in vitro spheroid viability and tumour cell migration was determined by microscopic techniques. Pre-irradiated glioblastoma spheroids were implanted into brains of immunosuppressed rats. Long-term tumour development was assessed by magnetic resonance (MR) imaging, and animal survival was recorded. An immunohistochemical analysis was performed on the sectioned rat brains.
RESULTS: Both un-irradiated and irradiated spheroids remained viable during 2 months in culture, but a dose-dependent inhibition of tumour growth and migration was seen. MR imaging 4 weeks after implantation also showed a dose-dependent inhibition in tumour development. Median animal survival times were 25.5 days (control group), 43 days (12 Gy group) and 96 days (24 Gy group). The study of in vivo long-term radiation effects on the remaining viable tumour population showed no difference in Ki-67 labelling index and microvascular density before and after radiosurgery.
CONCLUSIONS: A dose-dependent inhibition of tumour growth and invasion, as well as a dose-dependent increase in animal survival was observed. The model system described is well suited for assessing the radiobiological effects of Gamma Knife radiosurgery. The results indicate that radiosurgery of malignant gliomas might be effective in controlling tumour progression in selected glioblastoma patients.

Entities:  

Mesh:

Year:  2006        PMID: 16955221     DOI: 10.1007/s11060-006-9240-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  Effect of single dose irradiation on human glioblastoma spheroids in vitro.

Authors:  Fabian Fehlauer; Lukas J A Stalpers; John Panayiotides; Patricia Kaaijk; Dionisio González González; Sieger Leenstra; Paul van der Valk; Peter Sminia
Journal:  Oncol Rep       Date:  2004-02       Impact factor: 3.906

2.  Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

Authors:  Anita Mahajan; Ian E McCutcheon; Dima Suki; Eric L Chang; Samuel J Hassenbusch; Jeffrey S Weinberg; Almon Shiu; Moshe H Maor; Shiao Y Woo
Journal:  J Neurosurg       Date:  2005-08       Impact factor: 5.115

3.  Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.

Authors:  Rupavathana Mahesparan; Tracy-Ann Read; Morten Lund-Johansen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Olav Engebraaten
Journal:  Acta Neuropathol       Date:  2002-11-01       Impact factor: 17.088

4.  Effects of radiation on a three-dimensional model of malignant glioma invasion.

Authors:  G S Bauman; B J Fisher; W McDonald; V R Amberger; E Moore; R F Del Maestro
Journal:  Int J Dev Neurosci       Date:  1999 Aug-Oct       Impact factor: 2.457

5.  Fractionated radiosurgery for 9L gliosarcoma in the rat brain.

Authors:  J H Kim; M S Khil; A Kolozsvary; J A Gutierrez; S L Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-11-01       Impact factor: 7.038

6.  Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro.

Authors:  Jan Gliemroth; Thomas Feyerabend; Christiane Gerlach; Hans Arnold; A Jorge A Terzis
Journal:  Neurosurg Rev       Date:  2003-02-12       Impact factor: 3.042

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Morphological redifferentiation in a malignant astrocytic tumor after gamma knife radiosurgery.

Authors:  György T Szeifert; Nicolas Massager; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

9.  The effects of irradiation on cell migration from glioblastoma multiforme biopsy spheroids.

Authors:  C E Kleynen; T R Stoter; T M Tadema; L J Stalpers; C M Dirven; S Leenstra; P Van Der Valk; B J Slotman; P Sminia
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

10.  Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines.

Authors:  N Cordes; B Hansmeier; C Beinke; V Meineke; D van Beuningen
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more
  4 in total

1.  Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.

Authors:  Nagababu Chinnam; Prasanna K Dadi; Shahbaaz A Sabri; Mubeen Ahmad; M Anaul Kabir; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2010-03-25       Impact factor: 6.953

2.  Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging.

Authors:  Klaus Kruttwig; Chantal Brueggemann; Eric Kaijzel; Susanne Vorhagen; Thomas Hilger; Clemens Löwik; Mathias Hoehn
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

3.  The invasiveness of five medulloblastoma cell lines in collagen gels.

Authors:  Adrianna Ranger; Warren McDonald; Emi Moore; Rolando Delmaestro
Journal:  J Neurooncol       Date:  2009-07-15       Impact factor: 4.130

Review 4.  Spherical cancer models in tumor biology.

Authors:  Louis-Bastien Weiswald; Dominique Bellet; Virginie Dangles-Marie
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.